| In vivo effects of the anti–interleukin‐6 receptor inhibitor tocilizumab on the B cell compartment P Roll, K Muhammad, M Schumann, S Kleinert, H Einsele, T Dörner, ... Arthritis & Rheumatism 63 (5), 1255-1264, 2011 | 104 | 2011 |
| CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients J Pieper, J Herrath, S Raghavan, K Muhammad, R van Vollenhoven, ... BMC immunology 14 (1), 1-9, 2013 | 103 | 2013 |
| NFATc1 controls the cytotoxicity of CD8+ T cells S Klein-Hessling, K Muhammad, M Klein, T Pusch, R Rudolf, J Flöter, ... Nature communications 8 (1), 1-15, 2017 | 76 | 2017 |
| NFATc1 induction in peripheral T and B lymphocytes M Hock, M Vaeth, R Rudolf, AK Patra, DAT Pham, K Muhammad, T Pusch, ... The Journal of Immunology 190 (5), 2345-2353, 2013 | 50 | 2013 |
| CD27-IgD-memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis Z Mahmood, K Muhammad, M Schmalzing, P Roll, T Dörner, HP Tony Arthritis research & therapy 17 (1), 1-11, 2015 | 44 | 2015 |
| Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory … K Muhammad, P Roll, T Seibold, S Kleinert, H Einsele, T Dörner, HP Tony Annals of the rheumatic diseases 70 (8), 1507-1510, 2011 | 41 | 2011 |
| Delayed acquisition of somatic hypermutations in repopulated IGD+ CD27+ memory B cell receptors after rituximab treatment K Muhammad, P Roll, H Einsele, T Dörner, HP Tony Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 40 | 2009 |
| Focus: Skin: Current Developments in the Immunology of Psoriasis F Grän, A Kerstan, E Serfling, M Goebeler, K Muhammad The Yale journal of biology and medicine 93 (1), 97, 2020 | 38 | 2020 |
| NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells H Alrefai, K Muhammad, R Rudolf, DAT Pham, S Klein-Hessling, AK Patra, ... Nature communications 7 (1), 1-13, 2016 | 38 | 2016 |
| Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 HH Ellah N , Gad S , Muhammad K, Batiha G Nanomedicine, 2020 | 37 | 2020 |
| NF‐κB factors control the induction of NFATc1 in B lymphocytes K Muhammad, H Alrefai, R Marienfeld, DAT Pham, K Murti, AK Patra, ... European journal of immunology 44 (11), 3392-3402, 2014 | 23 | 2014 |
| Architecture and expression of the nfatc1 gene in lymphocytes R Rudolf, R Busch, AK Patra, K Muhammad, A Avots, JC Andrau, ... Frontiers in immunology 5, 21, 2014 | 23 | 2014 |
| RF positivity has substantial influence on the peripheral memory B-cell compartment and its modulation by TNF inhibition P Roll, K Muhammad, M Schumann, S Kleinert, HP Tony Scandinavian journal of rheumatology 41 (3), 180-185, 2012 | 20 | 2012 |
| Effect of ATG‐F on B‐cell reconstitution after hematopoietic stem cell transplantation P Roll, K Muhammad, G Stuhler, U Grigoleit, H Einsele, HP Tony European journal of haematology 95 (6), 514-523, 2015 | 13 | 2015 |
| Long-term repopulation of peripheral B-cell subsets after single and repeated rituximab infusions in patients with rheumatoid arthritis P Roll, Z Mahmood, K Muhammad, M Feuchtenberger, T Dörner, HP Tony Clin Exp Rheumatol 33 (3), 347-353, 2015 | 13 | 2015 |
| Multiepitope subunit vaccine design against covid-19 based on the spike protein of sars-cov-2: An in silico analysis HA Dar, Y Waheed, MH Najmi, S Ismail, HF Hetta, A Ali, K Muhammad Journal of immunology research 2020, 2020 | 12 | 2020 |
| A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development S Klein-Hessling, R Rudolf, K Muhammad, KP Knobeloch, MA Maqbool, ... Nature communications 7 (1), 1-14, 2016 | 12 | 2016 |
| T cells control chemokine secretion by keratinocytes T Rauschenberger, V Schmitt, M Azeem, S Klein-Hessling, K Murti, F Grän, ... Frontiers in immunology 10, 1917, 2019 | 11 | 2019 |
| Investigating virological, immunological, and pathological avenues to identify potential targets for developing covid-19 treatment and prevention strategies Z Mahmood, H Alrefai, HF Hetta, H A Kader, N Munawar, ... Vaccines 8 (3), 443, 2020 | 10 | 2020 |
| NFATc1 releases BCL6‐dependent repression of CCR2 agonist expression in peritoneal macrophages from Saccharomyces cerevisiae infected mice R Busch, K Murti, J Liu, AK Patra, K Muhammad, KP Knobeloch, ... European journal of immunology 46 (3), 634-646, 2016 | 9 | 2016 |
Matthias GoebelerUniversity of Würzburg, University of Heidelberg, University of Giessen, University of MünsterVerified email at klinik.uni-wuerzburg.de
